Successful management of deep facial burns in a patient with extensive third-degree burns: The role of a nanocrystalline silver dressing in facilitating resurfacing

International Wound Journal

Volumn 4, Issue 1, 2007, Pages 8-14

  Marazzi, Mario ^a   De Angelis, Armando ^a   Ravizza, Adriano ^a   Ordanini, Marco N ^a   Falcone, Leonarda ^a   Chiaratti, Anna ^a   Crovato, Francesca ^a   Calò, Donata ^a   Veronese, Silvio ^a   Rapisarda, Vincenzo ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Deep facial burns; Grafting; Infection control; Reconstructive surgery; Scars; Silver dressings

Indexed keywords

SILVER;

ADULT; ARTICLE; BODY SURFACE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; EMERGENCY CARE; EPITHELIZATION; ESCHARECTOMY; FACE BURN; HUMAN; KERATINOCYTE; MALE; PLASTIC SURGERY; PRIORITY JOURNAL; SKIN TRANSPLANTATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WOUND DRESSING;

EID: 34147160673     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2006.00263.x     Document Type: Article

References (27)

1. Barisoni D. Mortality rates and prognostic indices in 2615 burned patients. Burns 1990;16:373-6.
2. Ehrlich HP. The physiology of wound healing: a summary of normal and abnormal wound healing processes. Adv Wound Care 1998;11:326-8.
3. Pruitt BA, McManus AT. The changing epidemiology of infections in burn patients. World J Surg 1992;16:57-67.
4. Ward RS, Saffle JR. Topical agents in burn and wound care. Phys Ther 1995;75:526-38.
5. Demling RH, DeSanti L. Effects of silver on wound management. Wounds 2001;13(Suppl A):7-15.
6. Niedner R, Schopf E. Inhibition of wound healing by antiseptics. Br J Dermatol 1986;115(Suppl 31):41-4.
7. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of Acticoat* antimicrobial barrier dressing. J Burn Care Rehabil 1999;20:195-200.
8. Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings: in-vitro examination of two controlled release of silver dressings. Wounds 1998;10:179-88.
9. Wright JB, Lam K, Burrell RE. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control 1998;26:572-7.
10. Wright JB, Lam K, Hansen D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-50.
11. Burrell RE, Heggers JP, Davis GJ, Wright JB. Efficacy of silver-coated dressings as bacterial barriers in a rodent burn sepsis model. Wounds 1999;11:64-71.
12. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of a nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002;10:141-51.
13. Kirsner RW, Orsted H, Wright JB. Matrix metalloproteinases in normal and impaired wound healing: a potential role of nanocrystalline silver. Wounds 2001;13(Suppl C):4-12.
14. Fraser JF, Cuttle L, Kempf M, Kimble RM. Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg 2004;74:139-42.
15. Tredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat* silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998;19:531-7.
16. Demling RH, DeSanti L. The rate of re-epihelialization across meshed skin grafts is increased with exposure to silver. Burns 2002;28:264-6.
17. Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ostomy Wound Manage 2001;47:38-43.
18. Voigt DW, Paul CN. The use of Acticoat as silver impregnated Telfa dressing in a regional burn and wound care center: the clinicians view. Wounds 2001;13(Suppl B):11-20.
19. Cole JK, Engrav LH, Heimbach DM, Gibran NS, Costa BA. Early excision and grafting of face and neck burns in patients over 20 years. Plast Reconstr Surg 2002;109:1266-73.
20. MacLennan SE, Kitzmiller WJ, Mertens D, Warden GD, Neale HW. Scalp autografts and hair transfer to the face in the burned child. Plast Reconstr Surg 1998;102:1865-8.
21. Burke JF, Yannas IV, Quinby WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981;194:413-28.
22. Boyce ST. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 2002;183:445-56.
23. Boyce ST, Kagan RJ, Yakuboff KP, Meyer NA, Rieman NT, Greenhalgh DG, Warden GD. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 2002;235:269-79.
24. Hancock KA, Leigh IM. Cultured keratinocytes and keratinocyte grafts. Skin grafts from the laboratory can supplement autografts. BMJ 1989;299:1179-80.
25. Donati L, Magliacani G, Bormioli M, Signorini M, Baruffaldi Preis FW. Clinical experiences with keratinocytes grafts. Burns 1992;18:1:19-25.
26. Pandya AN, Woodward B, Parkhouse N. The use of cultured autologous keratinocytes with integra in the resurfacing of acute burns. Plast Reconstr Surg 1998;102:825-8.
27. Marazzi M, Pantaleone M, De Angelis A, Rapisarda V. A new approach in the prevention of infection in facial burns - clinical cases. In: Gottrup F, Romanelli M, editors. Proceedings of 14 EWMA Conference; Pisa; 2003. May; Pisa, Italy, p. 238.